EcoDrugPlus

Coagulation Factor X-Like

Ensembl ID : ENSKMAG00000008857
Gene Symbol: LOC108228942
3 Cross references
240 Possible Orthologues:

Coagulation Factor X-Like

Ensembl ID : ENSKMAG00000000674
Gene Symbol: LOC108229296
3 Cross references
78 Possible Orthologues:

Coagulation Factor Xi-Like

Ensembl ID : ENSKMAG00000017875
Gene Symbol: LOC108238782
2 Cross references
212 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSKMAG00000000662
Gene Symbol: CCDC6
3 Cross references
207 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSKMAG00000002048
Gene Symbol: LOC108247969
2 Cross references
231 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSKMAG00000002035
Gene Symbol: LOC108247974
2 Cross references
283 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSKMAG00000004150
Gene Symbol: CSF1R
3 Cross references
63 Possible Orthologues:

Complement C5

Ensembl ID : ENSKMAG00000021229
Gene Symbol: C5
2 Cross references
216 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSKMAG00000005176
Gene Symbol: CRHR1
3 Cross references
162 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSKMAG00000012851
Gene Symbol: CCND1
3 Cross references
231 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSKMAG00000014999
Gene Symbol: CDK1
3 Cross references
247 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSKMAG00000016443
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).